Overview
Palmoplantar keratoderma-spastic paralysis syndrome is a very rare inherited condition that affects both the skin and the nervous system at the same time. It is sometimes called Charcot-Marie-Tooth disease with palmoplantar keratoderma, or referred to by the names of the doctors who first described it. The condition causes two main problems: thick, hardened skin on the palms of the hands and the soles of the feet (called palmoplantar keratoderma), and progressive muscle stiffness and weakness in the legs due to damage to the nerves that control movement (called spastic paralysis or spastic paraplegia). The skin changes usually appear in childhood and can cause discomfort, cracking, and difficulty with everyday tasks involving the hands and feet. The neurological symptoms, including leg stiffness, muscle weakness, and difficulty walking, tend to develop over time and can gradually worsen. Some people also experience changes in sensation, such as numbness or tingling in the limbs. There is currently no cure for this syndrome. Treatment focuses on managing symptoms. Skin care routines, moisturizers, and keratolytic creams can help soften the thickened skin. Physical therapy and mobility aids can help maintain walking ability and independence for as long as possible. A team of specialists is usually needed to provide the best care.
Key symptoms:
Thick, hardened skin on the palms of the handsThick, hardened skin on the soles of the feetLeg stiffness and muscle tightness (spasticity)Progressive weakness in the legsDifficulty walking or changes in the way a person walksNumbness or tingling in the hands or feetCracking or painful skin on the palms and solesReduced coordination or balance problemsMuscle cramps or spasms in the legs
Clinical phenotype terms (12)— hover any for plain English
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Palmoplantar keratoderma-spastic paralysis syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Palmoplantar keratoderma-spastic paralysis syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Palmoplantar keratoderma-spastic paralysis syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Palmoplantar keratoderma-spastic paralysis syndrome.
Community
No community posts yet. Be the first to share your experience with Palmoplantar keratoderma-spastic paralysis syndrome.
Start the conversation →Latest news about Palmoplantar keratoderma-spastic paralysis syndrome
No recent news articles for Palmoplantar keratoderma-spastic paralysis syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What genetic tests should I have to confirm the diagnosis and identify the specific gene involved?,How quickly might my neurological symptoms progress, and what signs should I watch for?,What skin care products or treatments do you recommend for the thickened skin on my hands and feet?,What physical therapy program would be most helpful for maintaining my walking ability?,Are there any clinical trials or research studies I could participate in?,Should my family members be tested for this condition?,What mobility aids or home modifications should I consider now or plan for in the future?
Common questions about Palmoplantar keratoderma-spastic paralysis syndrome
What is Palmoplantar keratoderma-spastic paralysis syndrome?
Palmoplantar keratoderma-spastic paralysis syndrome is a very rare inherited condition that affects both the skin and the nervous system at the same time. It is sometimes called Charcot-Marie-Tooth disease with palmoplantar keratoderma, or referred to by the names of the doctors who first described it. The condition causes two main problems: thick, hardened skin on the palms of the hands and the soles of the feet (called palmoplantar keratoderma), and progressive muscle stiffness and weakness in the legs due to damage to the nerves that control movement (called spastic paralysis or spastic par
How is Palmoplantar keratoderma-spastic paralysis syndrome inherited?
Palmoplantar keratoderma-spastic paralysis syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Palmoplantar keratoderma-spastic paralysis syndrome typically begin?
Typical onset of Palmoplantar keratoderma-spastic paralysis syndrome is childhood. Age of onset can vary across affected individuals.